Isomorphic Labs secures $600m to supercharge AI drug discovery
FierceBiotech - 31-Mar-2025Backed by Nobel science, the Alphabet spinout speeds up AI drug development
FierceBiotech
Web resource providing the latest biotech news, articles, and resources related to biotech company news
Biopharma is a fast-growing world where big ideas come along daily. Our readers rely on Fierce Biotech for the latest news, analysis and data on drugs and the companies that make them. Fierce Biotech covers the biopharma waterfront, from drug development through the entire lifecycle—tracking regulatory approvals, payer negotiations, manufacturing, marketing, patent fights, government investigations and regulation, M&A deals and beyond. Our aim is to analyze the day's news, showing readers not only what they need to know, but why they need to know it. Beyond the daily, the Fierce Biotech team produces special reports that take stock of the industry's products and finances, and shed new light on industry trends.
Visit website: https://www.fiercebiotech.com/
Details last updated 08-Feb-2019
People at FierceBiotech
Helen Floersh
Writer at Fierce Biotech, covering developments in basic science research and early-stage drug development.
Articles sourced from FierceBiotech
Bit.bio cuts 25% of staff as it shifts from therapy development to lab research
FierceBiotech - 19-Mar-2025Company aims to grow its product line and biotech partnerships
Vertex ends gene editing deal with Verve amid R&D shift
FierceBiotech - 27-Feb-2025Verve regains full rights to its liver disease program as it moves forward independently
Gene therapy restores hearing in children with rare deafness
FierceBiotech - 24-Feb-2025Regeneron’s DB-OTO offers new hope for genetic hearing loss
Cell therapy breakthrough offers new hope for type 1 diabetes
FierceBiotech - 08-Jan-2025Early trial results show promise for insulin production without immune suppression
ALS drug trials face setbacks but offer glimmers of hope
FierceBiotech - 07-Jan-2025Fosigotifator and DNL343 miss key goals, sparking calls for deeper analysis and longer studies
Khondrion's sonlicromanol faces setback in phase 2 trial, but holds onto hope
FierceBiotech - 22-Nov-2024Long-term follow-up data and post-hoc analyses fuel optimism for treating mitochondrial diseases
AI-developed drug improves lung function in idiopathic pulmonary fibrosis
FierceBiotech - 12-Nov-2024Drug improved chronic cough symptoms, contributing to a better quality of life\
Horizon Surgical raises $30M to enhance robotic cataract surgery
FierceBiotech - 21-Oct-2024Their Polaris system aims to improve cataract removal precision and consistency
Gilead strikes $35m AI drug discovery deal with Genesis
FierceBiotech - 10-Sep-2024The biotech’s advanced AI platform aims to unlock new treatments for challenging drug targets
Bioage prepares for IPO, targets obesity with new drug trials
FierceBiotech - 04-Sep-2024Biotech firm Bioage plans public debut as it advances promising obesity treatments
Race to treat rare disease heats up as Rafael and Cyclo join forces
FierceBiotech - 22-Aug-2024Pooling strengths to rival a competing therapy for Niemann-Pick type c1
Johnson & Johnson's Spine robot gets FDA clearance for advanced spine surgeries
FierceBiotech - 02-Aug-2024It will be available next year and is part of a series of advanced medical tools
Genentech discontinues cell therapy collaboration with Adaptimmune
FierceBiotech - 12-Apr-2024The company remains focused on its independent cancer drug development
Nanoscope's gene therapy offers hope for patients blinded by inherited retinal disease
FierceBiotech - 26-Mar-2024Phase 2 trial results show significant vision improvement, plans for FDA approval
MMI's surgical robot gears up for global rollout with $110M boost
FierceBiotech - 21-Feb-2024Symani's wristed instruments bring steady hands and big ambitions to microsurgery
Regenxbio-AbbVie gene therapy reduces eye injections for AMD patients
FierceBiotech - 17-Jan-2024Patients’ vision and retinal health remained stable after six months
Johnson & Johnson is developing a new robotic surgical system called Ottava
FierceBiotech - 10-Nov-2023Company is planning to begin clinical trials in the US in late 2024
Athersys faces setback as stroke therapy fails trial
FierceBiotech - 10-Oct-2023Enrollment paused, but $1.5 million secured from new partnership
World's first MRI-compatible surgical robot cleared by FDA for breast biopsies
FierceBiotech - 13-Sep-2023Safer, more accurate breast biopsies made possible with IGAR robot
Humacyte's bioengineered tissue outperforms synthetic grafts
FierceBiotech - 12-Sep-2023Human acellular vessel showed better results in vascular trauma repair
Neuralink's brain implant gets $280M in funding, eyes clinical trials
FierceBiotech - 08-Aug-2023FDA approves Neuralink's brain implant, patients can now sign up for trials
Voyager's new gene therapy targets amyloid plaques in Alzheimer's disease
FierceBiotech - 04-Aug-2023New treatment approach could be more effective in lowering the risk of serious side effects
J&J extends $30m deal with Nanobiotix for global co-development of radioenhancer
FierceBiotech - 10-Jul-2023NBTXR3 to enhance the effect of immunotherapies; plans for phase 3 trial in head and neck cancer
Unity Biotechnology's diabetic macular edema senolytic treatment shows promise at 48-week endpoint
FierceBiotech - 24-Apr-2023Corporate shift towards ophthalmology puts senolytics head-to-head against existing treatments
Novocure received European approval for its Tumor Treating Fields therapy
FierceBiotech - 11-Nov-2022This expansion follows earlier FDA approval in the U.S. With financing from JPMorgan
AgeX credit running out with substantial doubt it can continue
FierceBiotech - 15-Aug-2022Let's hope their research is either successful for the company or its successors
ForSight Robotics raises $55M for fully robotic cataract surgery
FierceBiotech - 22-Jul-2022ForSight Robotics main goal is to democratize sophisticated eye treatment procedures globally
Athersys’ stem cell therapy falls short in Japanese stroke trial
FierceBiotech - 20-May-2022Multistem shows promise in secondary measures but misses key endpoint
Satellite Bio raised $110M to push its tissue therapies to the clinic
FierceBiotech - 20-Apr-2022Bioengineered implanatable tissues can repair or replace diseases organs
Korify Capital plans to invest $100m in longevity and mental health space
FierceBiotech - 22-Dec-2021Aiming to invest in 15-20 biotech firms, including Cambrian Biopharma, to target drivers of ageing
Virtual Incision's MIRA robotic system successfully performed world's first laparoscopic surgery
FierceBiotech - 01-Dec-2021Raised $46 million to commercialize and advance robot-assisted surgical technology
Robotic surgery system recalled due to software bug affecting instrument positioning
FierceBiotech - 01-Nov-2021Only 3 reported incidents but risk of serious injury is high with platform designed for neurosurgery
FDA puts clinical hold on Allogenic CAR T therapy due to safety concerns
FierceBiotech - 08-Oct-2021Chromosome abnormality reported in a clinical trial raises doubts on patient safety
Elevian has secured $40 million for anti-aging diseases and heart stroke
FierceBiotech - 17-Sep-2021$40 million for clinical research, lead program-stroke recovery focuses GDF11
Owlstone Medical raised $58M to advance its breath biopsy technology
FierceBiotech - 07-Sep-2021Developing painless tests to detect lung cancer, liver diseases, respiratory diseases, and gut health
AbbVie and Calico extends their collab up to 2025 with a $1 billion deal
FierceBiotech - 27-Jul-2021Supports ageing research and advancing early-stage projects to phase 2 trials over the next decade
Unity's senolytic drug reports positive phase 1 data in eye disease patients
FierceBiotech - 06-Jul-2021Begun phase 2 trial including patients with early stage of disease to test its safety and effectiveness
Medtronic's Hugo robot performed first-ever minimally invasive surgery in Chile
FierceBiotech - 22-Jun-2021Low-cost, compact robot to help surgeons - yet to receive approval in the US and Europe
Insitro secures $400 million in series C funding
FierceBiotech - 15-Mar-2021Giant leap towards developing transformative medicines powered by machine learning
Bionaut labs developed microbots to tackle untreatable cancers
FierceBiotech - 03-Mar-2021Real injectable robots delivering drugs exactly where they're needed - the future is here!
BioNTech's vaccine prevents multiple sclerosis in rodents
FierceBiotech - 07-Jan-2021Developed through a novel mRNA technology used in vaccine for COVID-19
Elevian raises $15M in preclinical work towards clinical antiaging
FierceBiotech - 24-Nov-2020rGDF11 in clinic targets multiple age related disease therapies
Bristol Myers and insitro harness AI to tackle ALS and dementia
FierceBiotech - 28-Oct-2020A $2B partnership seeks to transform drug discovery with AI and stem cell models
Illumina reunites with cancer testing firm Grail, worth $8 billion deal
FierceBiotech - 21-Sep-2020Marks new era in advancing screening and early diagnosis of cancer technology
Casma Therapeutics raises $50m to boost cellular waste management therapies
FierceBiotech - 10-Sep-2020Novel autophagy-based approaches target muscular dystrophy and other challenging diseases
$95M raised by Taysha for clinical trials of four new gene therapies
FierceBiotech - 05-Aug-2020Company has gathered support from investors to quickly lead therapies to clinic then market
Deep Longevity investors bet on growing need for aging and longevity biomarkers
FierceBiotech - 15-Jul-2020Biological clocks are a moving target so they'll need other researchers to corroborate their analysis
Cell therapy could be the solution for multiple sclerosis and Huntington's
FierceBiotech - 19-May-2020Transplanting glial cells in worked in mouse models affected with MS
Adicet merges with resTorbio for CAR T-cell therapy pipeline funding
FierceBiotech - 30-Apr-2020The deal moves company forward to initiating phase 1 trials in non-Hodgkin lymphoma next year
AI and CRISPR Key to Stem Cell Use in Regenerative Medicine
FierceBiotech - 20-Nov-2019Functional organs from stem cells possible through machine learning and gene-editing
Non-surgical medical robots for help by ABB
FierceBiotech - 10-Oct-2019Pipetting, sorting test tubes or preparing medicines by robots in near future
Gen1e unveils new era in p38 alpha kinase inhibition for inflammatory diseases
FierceBiotech - 31-Jul-2019A breath of fresh air for patents with acute respiratory distress syndrome
Hearing loss drug triggers improvements in phase 1/2 trials
FierceBiotech - 09-Apr-2019Restoring hearing and vision would make many people's lives significantly easier
New $100m fund wants to give us 30 years extra healthspan
FierceBiotech - 05-Feb-2019Aiming for a market of billions of people, not just the richest
Aging focused biotechs forms AI based joint venture
FierceBiotech - 14-Aug-2018Groundbreaking research biotechs performs aging research together for longevity
Attempts to revolutionize pathogen detection
FierceBiotech - 25-Jul-2018Treatment could be more effective if we can identify resistance patterns at the begining
